To systematically summarize the evidence for photobiomodulation therapy (PBMT) in the prevention and treatment of oral mucositis (OM) in patients undergoing cancer treatment. An electronic search was conducted in 8 databases and grey literature.
Background:
PBMT is recommended for the management of OM resulting from cancer treatment, with several systematic reviews (SRs) being published in recent years on this topic.
Methods:
Only SRs with outcomes from clinical trials were included, with no language or year restriction. The AMSTAR 2 tool was used to assess the methodological quality of the SRs.
Results:
Five thousand eight hundred fifty-six references were found, and 16 were selected for this review. OM prevention and treatment were favorable for PBMT in most studies, with a significant reduction in OM severity. Most studies obtained moderate confidence.
Conclusions:
PBMT represents an effective strategy in the management of OM, and this evidence is supported by studies with acceptable methodological quality.
PulitoC, CristaudoA, PortaC, et al.Oral mucositis: The hidden side of cancer therapy. J Exp Clin Cancer Res, 2020; 39(1):210; doi: 10.1186/s13046-020-01715-7.
LallaRV, SaundersDP, PetersonDE. Chemotherapy or radiation-induced oral mucositis. Dent Clin North Am, 2014; 58(2):341–349; doi: 10.1016/j.cden.2013.12.005.
5.
EltingLS, CooksleyCD, ChambersMS, et al.Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys, 2007; 68(4):1110–1120; doi: 10.1016/j.ijrobp.2007.01.053.
6.
ChanCWH, LawBMH, WongMMH, et al.Oral mucositis among Chinese cancer patients receiving chemotherapy: Effects and management strategies. Asia Pac J Clin Oncol, 2021; 17(2):e10–e17; doi: 10.1111/ajco.13349.
7.
JehnP, StierR, TavassolF, et al.Physical and psychological impairments associated with mucositis after oral cancer treatment and their impact on quality of life. Oncol Res Treat, 2019; 42(6):342–349; doi: 10.1159/000499720.
8.
EladS, ChengKKF, LallaRV, et al.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 2020; 126(19):4423–4431; doi: 10.1002/cncr.33100.
9.
ZadikY, AranyPR, FregnaniER, et al.Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer, 2019; 27(10):3969–3983; doi: 10.1007/s00520-019-04890-2.
10.
CronshawM, ParkerS, AnagnostakiE, et al.Photobiomodulation and oral mucositis: A systematic review. Dent J (Basel), 2020; 8(3):87; doi: 10.3390/dj8030087.
11.
ChungH, DaiT, SharmaSK, et al.The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng, 2012; 40(2):516–533; doi: 10.1007/s10439-011-0454-7.
12.
KlausnerG, TroussierI, CanovaCH, et al.Clinical use of photobiomodulation as a supportive care during radiation therapy. Support Care Cancer, 2022; 30(1):13–19; doi: 10.1007/s00520-021-06518-w.
13.
ZechaJA, Raber-DurlacherJE, NairRG, et al.Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 2: Proposed applications and treatment protocols. Support Care Cancer, 2016; 24(6):2793–2805; doi: 10.1007/s00520-016-3153-y.
14.
ZechaJA, Raber-DurlacherJE, NairRG, et al.Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 1: Mechanisms of action, dosimetric, and safety considerations. Support Care Cancer, 2016; 24(6):2781–2792; doi: 10.1007/s00520-016-3152-z.
15.
BrandaoTB, Morais-FariaK, RibeiroACP, et al.Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: Retrospective outcomes and safety analyses. Support Care Cancer, 2018; 26(7):2417–2423; doi: 10.1007/s00520-018-4046-z.
16.
PaulettoP, Ruales-CarreraE, MezzomoLA, et al.Clinical performance of short versus standard dental implants in vertically augmented bone: An overview of systematic reviews. Clin Oral Investig, 2021; 25(11):6045–6068; doi: 10.1007/s00784-021-04095-0.
17.
LiangM, YanL, MeiZ, et al.Methodological and reporting quality evaluation of meta-analyses on the Chinese herbal preparation Zheng Qing Feng Tong Ning for the treatment of rheumatoid arthritis. BMC Complement Med Ther, 2020; 20(1):195; doi: 10.1186/s12906-020-02978-5.
18.
SheaBJ, ReevesBC, WellsG, et al.AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017; 358:j4008; doi: 10.1136/bmj.j4008.
19.
BjordalJM, BensadounRJ, TunerJ, et al.A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Supportive Care In Cancer, 2011; 19(8):1069–1077; doi: 10.1007/s00520-011-1202-0.
20.
OberoiS, Zamperlini-NettoG, BeyeneJ, et al.Effect of prophylactic low level laser therapy on oral mucositis: A systematic review and meta-analysis. PLoS One, 2014; 9(9):e107418; doi: 10.1371/journal.pone.0107418.
21.
Al-RudayniAHM, GopinathD, MaharajanMK, et al.Efficacy of photobiomodulation in the treatment of cancer chemotherapy-induced oral mucositis: A meta-analysis with trial sequential analysis. Int J Environ Res Public Health, 2021; 18(14):7418; doi: 10.3390/ijerph18147418.
22.
LaiCC, ChenSY, TuYK, et al.Effectiveness of low level laser therapy versus cryotherapy in cancer patients with oral mucositis: Systematic review and network meta-analysis. Crit Rev Oncol Hematol, 2021; 160:103276; doi: 10.1016/j.critrevonc.2021.103276.
23.
AnschauF, WebsterJ, CapraMEZ, et al.Efficacy of low-level laser for treatment of cancer oral mucositis: a systematic review and meta-analysis. Lasers Med Sci, 2019; 34(6):1053–1062; doi: 10.1007/s10103-019-02722-7.
24.
CamposTM, do Prado Tavares SilvaCA, SobralAPT, et al.Photobiomodulation in oral mucositis in patients with head and neck cancer: A systematic review and meta-analysis followed by a cost-effectiveness analysis. Support Care Cancer, 2020; 28(12):5649–5659; doi: 10.1007/s00520-020-05613-8.
25.
PengJ, ShiY, WangJ, et al.Low-level laser therapy in the prevention and treatment of oral mucositis: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol, 2020; 130(4):387–397.e9; doi: 10.1016/j.oooo.2020.05.014.
26.
MazhariF, ShiraziAS, ShabzendehdarM. Management of oral mucositis in pediatric patients receiving cancer therapy: A systematic review and meta-analysis. Pediatr Blood Cancer, 2019; 66(3):e7403; doi: 10.1002/pbc.27403.
27.
da SilvaBM, ProsdócimoML, GaspariniLR, et al.Most used photobiomodulation dosimetry parameters to treat oral mucositis after preconditioning for hematopoietic stem cell transplantation: systematic review and meta-analysis. Support Care Cancer, 2022; 30(5):3721–3732; doi: 10.1007/s00520-022-06817-w.
28.
de LimaVHS, de Oliveira-NetoOB, da Hora SalesPH, et al.Effectiveness of low-level laser therapy for oral mucositis prevention in patients undergoing chemoradiotherapy for the treatment of head and neck cancer: A systematic review and meta-analysis. Oral Oncol, 2020; 102:104524; doi: 10.1016/j.oraloncology.2019.104524.
29.
Kauark-FontesE, Rodrigues-OliveiraL, EpsteinJB, et al.Cost-effectiveness of photobiomodulation therapy for the prevention and management of cancer treatment toxicities: A systematic review. Support Care Cancer, 2021; 29(6):2875–2884; doi: 10.1007/s00520-020-05949-1.
30.
Peralta-MamaniM, da SilvaBM, da Silva PintoAC, et al.Low-level laser therapy dosimetry most used for oral mucositis due to radiotherapy for head and neck cancer: A systematic review. Crit Rev Oncol Hematol, 2019; 138:14–23; doi: 10.1016/j.critrevonc.2019.03.009.
31.
HeM, ZhangB, ShenN, et al.A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur J Pediatr, 2018; 177(1):7–17; doi: 10.1007/s00431-017-3043-4.
32.
RedmanMG, HarrisK, PhillipsBS. Low-level laser therapy for oral mucositis in children with cancer. Arch Dis Child, 2022; 107(2):128–133; doi: 10.1136/archdischild-2020-321216.
33.
FigueiredoALP, LinsL, CattonyAC, et al.Laser therapy in the control of oral mucositis: A meta-analysis. Rev Assoc Med Bras (1992), 2013; 59(5):467–474; doi: 10.1016/j.ramb.2013.08.003.
34.
WangD, YiX, YanR, et al.Effect of low-level laser therapy on prevention of oral mucositis in patients treated with radiotherapy and chemotherapy. Nurs Integr Tradit Chin Western Med, 2019; 5(2):57–63; doi: 10.1199/7/nitcwm.201902014.
35.
HodgsonBD, MargolisDM, SalzmanDE, et al.Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. Support Care Cancer, 2012; 20(7):1405–1415; doi: 10.1007/s00520-011-1223-8.
EnwemekaCS. The place of coherence in light induced tissue repair and pain modulation. Photomed Laser Surg, 2006; 24(4):457; doi: 10.1089/pho.2006.24.457.
38.
GuimaraesDM, OtaTMN, Da SilvaDAC, et al.Low-level laser or LED photobiomodulation on oral mucositis in pediatric patients under high doses of methotrexate: Prospective, randomized, controlled trial. Support Care Cancer, 2021; 29(11):6441–6447; doi: 10.1007/s00520-021-06206-9.
39.
HonórioHM. Systematic reviews: the world that didn't stop during the pandemic. Braz Dent Sci, 2021; 24(4):3272; doi: 10.1429/5/bds.2021.v24i4.3272.
40.
SchubertMM, EduardoFP, GuthrieKA, et al.A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer, 2007; 15(10):1145–1154; doi: 10.1007/s00520-007-0238-7.
41.
GobboM, VerzegnassiF, RonfaniL, et al.Multicenter randomized, double-blind controlled trial to evaluate the efficacy of laser therapy for the treatment of severe oral mucositis induced by chemotherapy in children: LaMPO RCT. Pediatr Blood Cancer, 2018; 65:e27098.
42.
AmadoriF, BardelliniE, ContiG, et al.Low-level laser therapy for treatment of chemotherapy-Induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers Med Sci, 2016:31:1231–1236.
43.
LegouteF, BensadounRJ. Seegers V, et al. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised triple blind, multicentre Phase III trial. Radiat Oncol, 2019:14:83.
44.
AhmedKH, HusseinSA, NooriAJ, et al.Evaluation of low level laser therapy in the management of chemotherapy-induced oral mucositis in pediatric and young cancer patients: A randomized clinical trial. Eur Sci, 2015; 11:209–222.
45.
Kuhn a, PortoFA, MiragliaP, et al.Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children. J Pediatr Hematol Oncol, 2009; 31:33–37.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
